Overview
- 7 public-safe observations are available for this inspection.
- 7 structured CFR citations are represented.
- 4 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
SOPs not followed / documented
Cited by Sean R Marcsisin, Daniel L Zheng, Lori M Newman, Leanna M Slarsky
Investigations of discrepancies, failures
Cited by Sean R Marcsisin, Daniel L Zheng, Lori M Newman, Leanna M Slarsky
Procedures not in writing, fully followed
Cited by Sean R Marcsisin, Daniel L Zheng, Lori M Newman, Leanna M Slarsky
Training--operations, GMPs, written procedures
Cited by Sean R Marcsisin, Daniel L Zheng, Lori M Newman, Leanna M Slarsky
Cleaning / Sanitizing / Maintenance
Cited by Sean R Marcsisin, Daniel L Zheng, Lori M Newman, Leanna M Slarsky
Inspected site
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.25(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.67(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 1x |
Source document
Form 483 source document
The source document is available to authorized Atlas users.
Full 483 report
Get the verbatim text of all 7 observations
The source PDF, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere